1. Tian, Shan, Peng, Pailan, Li, Jiao, Zeng, Zhi, Dong, Weiguo. 2020. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. In Aging, 12, 3574-3593. doi:10.18632/aging.102831. https://pubmed.ncbi.nlm.nih.gov/32091407/
2. Zhang, Shuyuan, Zhang, Weiwei, Wu, Bin, Zou, Yangfan, Sun, Caixing. . Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI. In Medicine, 101, e31418. doi:10.1097/MD.0000000000031418. https://pubmed.ncbi.nlm.nih.gov/36397358/
3. Xia, Guang, Wu, Song, Luo, Ke, Cui, Xiaoyu. 2023. By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma. In Frontiers in oncology, 13, 1180191. doi:10.3389/fonc.2023.1180191. https://pubmed.ncbi.nlm.nih.gov/37091161/
4. Wang, Yu, Gu, Weigang, Wen, Weiwei, Zhang, Xiaofeng. 2022. SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis. In Frontiers in genetics, 12, 756094. doi:10.3389/fgene.2021.756094. https://pubmed.ncbi.nlm.nih.gov/35058967/
5. Zhang, Hailing, Yan, Xiaodi, Gu, Hongmei, Xue, Qiang, Liu, Xiancheng. . High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma. In Journal of thoracic disease, 14, 4785-4802. doi:10.21037/jtd-22-1518. https://pubmed.ncbi.nlm.nih.gov/36647484/